Evidence map›Paper›PMID 41810075›Full record

ReviewExploration (Beijing, China)2026

Scar Inhibition in Wound Healing: Mechanisms, Design, and Recent Advances.

Yong Kang, Yiwen Yang, Bin Yao, Zhuhong Zhang, Xiaoyuan Ji

Abstract readReview
In one paragraph

Review in Exploration (Beijing, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Electric-based dressing for wound management.Frontiers in cellular and infection microbiology · 2026
    Review
  5. A PIEZO-Gated Mechanotransduction Timing Window Governs Scar Commitment in Wound Healing.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yong KangState Key Laboratory of Advanced Medical Materials and Devices Medical College, Tianjin University Tianjin China.
Yiwen YangState Key Laboratory of Advanced Medical Materials and Devices Medical College, Tianjin University Tianjin China.
Bin YaoState Key Laboratory of Advanced Medical Materials and Devices Medical College, Tianjin University Tianjin China.ORCID https://orcid.org/0000-0002-0709-8683
Zhuhong ZhangSchool of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University Yantai China.
Xiaoyuan JiState Key Laboratory of Advanced Medical Materials and Devices Medical College, Tianjin University Tianjin China.ORCID https://orcid.org/0000-0002-6768-2304

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scar inhibition plays a crucial role in wound healing, particularly in the prevention of excessive scar formation during skin repair. While scar formation is a natural part of the healing process, improper scarring can lead to functional impairment, cosmetic defects, and psychological impacts. Therefore, understanding the mechanisms behind scar inhibition and exploring therapeutic strategies is essential for improving clinical outcomes. This review summarizes the primary mechanisms of scar formation and inhibition, including the regulation of collagen deposition, modulation of the inflammatory response, and control of cell proliferation and migration. In recent years, novel therapeutic approaches have emerged for scar inhibition, including gene therapy, stem cell treatments, and localized drug delivery systems, and the use of biomaterials. These methods not only enhance the effectiveness of scar treatment but also improve the biocompatibility and durability of the healing process. Although some of these approaches have shown promising results in early-stage studies, challenges remain for clinical applications, such as the individualization of treatment plans and the sustainability of outcomes. Finally, this review discusses future research directions and proposes strategies to enhance the potential of scar inhibition therapies and their clinical translation.

Indexed as

biomaterialsimmune modulationscar inhibitionsignaling pathwayswound healing

Identifiers

PMID41810075
PMCPMC12970273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.